Application to the U.S. Food and Drug Administration (FDA) to grant emergency authorization for the coronavirus pill, was submitted by Merck pharmaceutical company, as reported by the The New York Times.
If the FDA gives the «green light» and approves Merck’s pill, it will be the first oral COVID-19 drug, since the one being developed by Pfizer It is expected to be ready by the end of the year.
The FDA will review Merck's data on the drug's safety and efficacy before making a decision, which may be reached within the next few weeks.
Data released last week indicated that The experimental antiviral drug Molnupiravir, developed by Merck & Co, cuts the risk of death or hospitalization due to severe COVID-19 in half.
It should be noted that in our country, the pharmaceutical company is known as MSD.
